Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02998840 · ClinicalTrials.gov registry record · Phase 2
A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
A Phase 2 study, sponsored by AOBiome.
- Completed
- Registry status
- Phase 2
- Development phase
- 132
- Enrollment target
NCT02998840 is a Phase 2 study that has completed, run by AOBiome. The registered enrollment target is 132 participants.
The verdict
NCT02998840, a Phase 2 study, has completed, sponsored by AOBiome.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 132 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate and compare the efficacy of B244 in treating patients with hypertension.
Interventions
- BIOLOGICAL Vehicle
- BIOLOGICAL B244
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-06-26 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02998840
The ClinicalTrials.gov registry entry for NCT02998840 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AOBiome, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT02998840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02998840 about?
NCT02998840 is a clinical study titled "A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure". The purpose of this study is to evaluate and compare the efficacy of B244 in treating patients with hypertension.
What is the current status of trial NCT02998840?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 132 participants. The study started on 2016-11. Estimated completion is 2017-06-26.
What interventions are being tested in trial NCT02998840?
The interventions under investigation include: Vehicle (BIOLOGICAL), B244 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02998840?
This trial is sponsored by AOBiome, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.